CERS Cerus Corp: Earnings per share for the last 12 months

Cerus Inc (CERS) - corporate logo

Risks for Cerus Corporation (CERS) are linked to the high cost of clinic equipment and shifts in insurance payouts, which is confirmed by the linear price action on the chart, where EPS stands at 55.80. Cerus Corporation (CERS) relies on a global reagent supply network to maintain high margins. The business maintains its leadership through a unique blood purification technology that creates significant barriers to entry for new market players.

CERS Cerus Inc: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/18/2026
Product sample of Cerus Corp

This metric measures the dynamics of net income per share over a rolling year, revealing the actual speed of business scaling. By analyzing the EPS YoY growth rate (trailing 12 months), an investor determines the sustainability of capitalization amid compressing market multiples. Any deceleration in this trend signals hidden risks, even with stable revenues. For Cerus Corporation (CERS), such a metric confirms the efficiency of the monopoly INTERCEPT system and the long-term dependence of hospitals on its technologies.

Competitor analysis for Cerus Corporation

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato STVN|Net earnings per share (EPS TTM) Teleflex Corp TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical Inc (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Medical ATRC|Earnings per share for the last twelve months STAAR Surgical (STAA)|ChromaDex - Earnings per share for the last 12 months|ZimVie Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANGO (AngioDynamics Inc)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Orthopedics Inc. MGRM|Sharps Technology, Inc. (STSS) - Earnings per share for the last twelve months|INFU - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months UTMD|Net earnings per one share for the last twelve months korumedical.com KRMD|Net earnings per share for the last 12 months NYXH (Nyxoah S.A.)|Net earnings per share for the last 12 months Microbot Medical, Inc MBOT|Pro-Dex Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ZTEK (Zentek Ltd.)|Elutia Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Milestone Scientific Corp MLSS|NEXGEL, Inc (NXGL) - Earnings per share for the last twelve months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)